CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
3,097,005
Share change
-101,638
Total reported value
$8,359,000
Price per share
$2.70
Number of holders
25
Value change
-$444,934
Number of buys
8
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q3 2017

As of 30 Sep 2017, CANCER GENETICS INC - COM (CGIX) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,097,005 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, UBS Group AG, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Fairbanks Capital Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, DIKER MANAGEMENT LLC, WEDBUSH SECURITIES INC, and THOMPSON DAVIS & CO., INC.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.